HLB bioStep Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28,602	41,157	46,174	68,799	14,873	6,158
Short-Term Investments	-	-	686.98	1,578	55,000	-
Trading Asset Securities	2,190	2,186	-	-	27,191	4,235
Cash & Short-Term Investments	30,792	43,343	46,861	70,377	97,064	10,393
Cash Growth	-17.30%	-7.51%	-33.41%	-27.49%	833.97%	-30.30%
Accounts Receivable	7,629	7,549	7,483	3,730	7,009	7,788
Other Receivables	288.68	451.02	1,035	337.14	2,738	662.43
Receivables	8,279	8,361	8,900	4,469	10,065	10,153
Inventory	1,754	1,491	1,511	1,551	1,650	2,920
Prepaid Expenses	112.56	47.9	132.68	249	133.97	10.39
Other Current Assets	7,904	7,363	5,073	2,767	512.37	5,520
Total Current Assets	48,842	60,606	62,478	79,413	109,426	28,996
Property, Plant & Equipment	38,228	37,936	52,094	40,678	39,626	39,867
Long-Term Investments	48,274	37,086	37,687	44,916	12,811	15,051
Goodwill	1,542	1,542	6,490	1,049	1,049	1,253
Other Intangible Assets	2,724	2,884	3,485	750.69	811.65	722.08
Long-Term Deferred Tax Assets	147.53	147.53	3,100	1,096	2,127	1,302
Other Long-Term Assets	14,496	14,904	2,274	2,841	6,316	7,414
Total Assets	154,729	155,575	168,329	171,714	172,187	94,626
Accounts Payable	1,832	1,471	1,904	1,573	2,050	1,648
Accrued Expenses	560.93	689.75	675.07	438.93	533.51	324.38
Short-Term Debt	24,577	24,363	28,644	54,316	1,689	1,189
Current Portion of Long-Term Debt	3,748	3,748	3,748	3,448	3,224	3,000
Current Portion of Leases	424.54	365.58	414.96	367.28	398.72	841.66
Current Income Taxes Payable	0.86	7.72	3.11	19.77	352.86	1,444
Other Current Liabilities	9,699	17,332	10,896	4,518	4,527	8,134
Total Current Liabilities	40,843	47,978	46,285	64,682	12,775	16,582
Long-Term Debt	1,592	1,795	1,569	2,017	85,911	10,690
Long-Term Leases	617.63	493.15	320.38	487.93	418.11	583
Pension & Post-Retirement Benefits	1,837	1,780	1,541	310.49	126.46	259.14
Other Long-Term Liabilities	2,403	2,592	1,800	643.61	753.88	151.03
Total Liabilities	47,293	54,638	51,515	68,141	99,984	28,265
Common Stock	8,716	8,701	8,673	7,863	7,053	765.19
Additional Paid-In Capital	46,951	85,993	84,861	60,104	31,827	29,661
Retained Earnings	43,417	5,364	23,265	30,727	31,366	34,476
Treasury Stock	-3,169	-5,201	-7,332	-1,422	-	-
Comprehensive Income & Other	6,947	1,416	2,407	4,318	30.94	-315.38
Total Common Equity	102,863	96,272	111,874	101,590	70,278	64,587
Minority Interest	4,573	4,665	4,940	1,983	1,925	1,774
Shareholders' Equity	107,436	100,937	116,814	103,573	72,202	66,361
Total Liabilities & Equity	154,729	155,575	168,329	171,714	172,187	94,626
Total Debt	30,960	30,765	34,696	60,637	91,641	16,304
Net Cash (Debt)	-168.07	12,578	12,165	9,740	5,424	-5,911
Net Cash Growth	-	3.40%	24.90%	79.57%	-	-
Net Cash Per Share	-9.46	743.97	724.38	634.81	387.40	-422.29
Filing Date Shares Outstanding	17.21	17.15	16.84	15.63	14.11	13.77
Total Common Shares Outstanding	17.21	17.15	16.84	15.63	14.11	13.77
Working Capital	7,999	12,628	16,193	14,731	96,651	12,414
Book Value Per Share	5975.78	5612.00	6643.72	6501.77	4982.08	4689.29
Tangible Book Value	98,596	91,846	101,899	99,790	68,417	62,612
Tangible Book Value Per Share	5727.95	5353.99	6051.33	6386.57	4850.15	4545.87
Land	15,541	15,541	27,576	15,253	15,253	13,417
Buildings	30,246	30,246	30,985	24,974	24,280	23,327
Construction In Progress	70	70	40	989.4	-	511.28